|
NEOG | Neogen Corp |
|
|
NEOG | Neogen Corp |
| In Vitro & In Vivo Diagnostic Substances |
| Book value per $ invested | $ 3.10 |
| Leverage | 37.38% |
| Market Cap | $ 2.0B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -596.3m |
| Margin | -69.34% |
Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.